Tempest Therapeutics Inc (NASDAQ: TPST) on Tuesday, plunged -1.82% from the previous trading day, before settling in for the closing price of $1.10. Within the past 52 weeks, TPST’s price has moved between $0.86 and $6.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 22.35%. With a float of $22.33 million, this company’s outstanding shares have now reached $26.57 million.
Let’s determine the extent of company efficiency that accounts for 17 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Tempest Therapeutics Inc (TPST) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Tempest Therapeutics Inc is 15.95%, while institutional ownership is 6.77%. The most recent insider transaction that took place on Aug 12 ’24, was worth 426,993. Before that another transaction happened on Aug 08 ’24, when Company’s 10% Owner sold 400,000 for $1.35, making the entire transaction worth $540,040. This insider now owns 597,940 shares in total.
Tempest Therapeutics Inc (TPST) Recent Fiscal highlights
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.48 earnings per share (EPS) for the period topping the consensus outlook (set at -0.57) by 0.09. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.35% per share during the next fiscal year.
Tempest Therapeutics Inc (NASDAQ: TPST) Trading Performance Indicators
Tempest Therapeutics Inc (TPST) is currently performing well based on its current performance indicators. A quick ratio of 2.17 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.61, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.38 in one year’s time.
Technical Analysis of Tempest Therapeutics Inc (TPST)
Looking closely at Tempest Therapeutics Inc (NASDAQ: TPST), its last 5-days average volume was 2.47 million, which is a jump from its year-to-date volume of 2.1 million. As of the previous 9 days, the stock’s Stochastic %D was 76.85%. Additionally, its Average True Range was 0.11.
During the past 100 days, Tempest Therapeutics Inc’s (TPST) raw stochastic average was set at 14.96%, which indicates a significant decrease from 62.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 74.08% in the past 14 days, which was lower than the 99.20% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2068, while its 200-day Moving Average is $2.5180. However, in the short run, Tempest Therapeutics Inc’s stock first resistance to watch stands at $1.1433. Second resistance stands at $1.2067. The third major resistance level sits at $1.2533. If the price goes on to break the first support level at $1.0333, it is likely to go to the next support level at $0.9867. Now, if the price goes above the second support level, the third support stands at $0.9233.
Tempest Therapeutics Inc (NASDAQ: TPST) Key Stats
Market capitalization of the company is 28.69 million based on 25,208K outstanding shares. Right now, sales total 0 K and income totals -29,490 K. The company made 0 K in profit during its latest quarter, and -9,570 K in sales during its previous quarter.
